PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL)

Q: What does CUSIP 74019P207 represent in this 13F holders report?

CUSIP 74019P207 is the security identifier for DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share used to aggregate holder disclosures.

Q: How many institutions held DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share in Q1 2024?

40 institutional investors reported DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share for Q1 2024. Use the holders table for investor-level position and value details.

CUSIP: 74019P207

Q1 2024 13F Holders as of 31 Mar 2024

Security type / class: Equity / Common Stock, $0.000005 par value per share
Total 13F shares: 3,155,622
Total 13F value: $42,757,614
Share change: +3,155,470
SEC-reported price per share: $13.56
Number of holders: 40
Value change: +$42,755,553
Number of buys: 39
Shares outstanding: 26,340,541

Security key

74019P207

Report period

Q1 2024

Institutions

Top holders

DTIL full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 PRECISION BIOSCIENCES INC SEC filings PRECISION BIOSCIENCES INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 74019P207

Newer quarter: Q3 2025

Recent filing periods:

Q2 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

NOVARTIS PHARMA AG

Disclosed value leader

NOVARTIS PHARMA AG

Comparable rows

0/15

Latest evidence

31 Dec 2023

3/4/5 13F Highest disclosed value: $4,590,753 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

NOVARTIS PHARMA AG has the largest disclosed position value at $4.59M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens NOVARTIS PHARMA AG's linked filing trail.

Disclosed position value Top 5

NOVARTIS PHARMA AG $4.59M

Capital World Investors $1.87M

VANGUARD GROUP INC $1.74M

Derek Jantz $1.51M

CITADEL ADVISORS LLC $1.27M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
NOVARTIS PHARMA AG	3/4/5 10%+ Owner 3/4/5	— class O/S missing	$4,590,753 12,407,440 shares	—	15 Jun 2022
Capital World Investors	13F Company 13F	— class O/S missing	$1,868,602 5,119,458 shares	—	31 Dec 2023
VANGUARD GROUP INC	13F Company 13F	— class O/S missing	$1,735,493 4,754,776 shares	—	31 Dec 2023
Derek Jantz	3/4/5 Chief Scientific Officer, Director 3/4/5	— mixed-class rows	$1,509,439 4,079,565 shares mixed-class rows	—	07 Jun 2022
CITADEL ADVISORS LLC	13F Company 13F	— class O/S missing	$1,265,003 3,465,763 shares	—	31 Dec 2023
TANG CAPITAL MANAGEMENT LLC	13F Company 13F	— class O/S missing	$1,241,000 3,400,000 shares	—	31 Dec 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,155,622

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q4 2025 Across Filers

Q4 2025 holders

Q1 2024 holders

Holder diff

-27

Investor	Q4 2025 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q4 2025 value	Q1 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend